Modern Meadow, a Nutley, New Jersey and Brooklyn, New York based biofabrication company, raised $130m in in Series C funding.
The round was led by Key Partners Capital with participation from Astanor Ventures, Horizons Ventures and Cape Capital.
The company intends to use the funds to invest in research and development across material science and biotechnology.
Co-founded by Andras Forgacs, Gabor Forgacs, Karoly Jakab and Francoise Marga in 2011 and led by newly appointed CEO Anna Bakst, Modern Meadow is a company that uses biofabrication to create sustainable materials. Its proprietary technology integrates design, biology, and material science. The company has a team of 90 people with expertise in molecular biology, material science, engineering, and design.